Celecoxib plus chemoradiotherapy for locally advanced rectal cancer: a phase II TCOG study.

Abstract

BACKGROUND To report the results of a phase II trial combining celecoxib and preoperative chemoradiotherapy (CRT) for locally advanced rectal cancer. PATIENTS AND METHODS Patients with clinical stage II or III rectal cancer were treated with radiotherapy of 44 Gy in 22 fractions. Concurrent chemotherapy consisted of oral tegafur-uracil and folinate on… (More)
DOI: 10.1002/jso.23538

Topics

6 Figures and Tables